← Back
$TMDX All transactions

TransMedics Group, Inc.

▲ BUY
7 / 10

Conviction

$ Value

$217K

Shares

1,858

Price

$117

Filed

Aug 8

Why this score? (7/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Hassanein Waleed H

Title

President & CEO

CIK

0001430466

Roles

Director Officer

Transaction Details

Transaction Date

2025-08-07

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

486,234

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $118.50 to $118.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. | The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $115.60 to $116.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. | The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $116.62 to $117.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Filing Info

Accession No.

0000950170-25-105907

Form Type

4

Issuer CIK

0001756262

Hassanein Waleed H's History

Date Ticker Type Value
2025-11-17 TMDX $1.0M
2025-08-07 TMDX $768K
2025-08-07 TMDX $217K
2025-08-06 TMDX $997K

Other Insiders at TMDX (90d)

Insider Bought Sold Last
Lovell Stephanie $178K 2026-03-04
Weill David $524K 2026-03-04
Corcoran Nicholas
See remarks
$413K 2026-03-02
Ranganath Anil P.
See remarks
$120K 2026-03-02
Hernandez Gerardo
Chief Financial Officer
$1.1M 2026-03-04
Cecere Giovanni
Chief Commercial Officer
2026-02-18